Serviço de Endoscopia Gastrointestinal do Hospital das Clínicas HCFMUSP, Departamento de Gastroenterologia, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, 05403-010, Brazil.
Center for Advanced Therapeutic Endoscopy, Division of Gastroenterology, Hepatology, and Nutrition, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Obes Surg. 2021 Jun;31(6):2743-2752. doi: 10.1007/s11695-021-05352-7. Epub 2021 Mar 30.
Intragastric balloon (IGB) is a minimally invasive and reversible therapy for weight loss with a good efficacy and safety profile. Introduced in the 1980s, IGBs have significantly evolved in the last couple of decades. They mechanically act by decreasing the volume of the stomach and its reservoir capacity, delaying gastric emptying, and increasing satiety leading to a subsequent weight loss. Despite the low rates of complications and mortality associated with IGBs, adverse events and complications still occur and can range from mild to fatal. This review aims to provide an update on the current scientific evidence in regard to complications and adverse effects of the use of the IGB and its treatment. This is the first comprehensive narrative review in the literature dedicated to this subject.
胃内球囊（IGB）是一种用于减肥的微创且可逆转的疗法，具有良好的疗效和安全性。IGB 于 20 世纪 80 年代推出，在过去几十年中得到了显著发展。其通过减少胃容量和储存能力、延迟胃排空、增加饱腹感来发挥机械作用，从而导致体重减轻。尽管 IGB 相关并发症和死亡率较低，但仍会发生不良事件和并发症，其严重程度可从轻到重不等。本综述旨在提供有关 IGB 使用及其治疗的并发症和不良反应的当前科学证据的最新信息。这是文献中第一篇专门针对该主题的全面叙述性综述。
